Longitudinal kinetics of the viral infection biomarker 3′-deoxy-3′,4′-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge models

Longitudinal kinetics of the viral infection biomarker 3′-deoxy-3′,4′-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge models

Abstract 3’-deoxy-3’,4’-didehydro-cytidine (ddhC) is a recently discovered host biomarker for viral infections, though its temporal kinetics remain unclear. This study tests the hypothesis that ddhC is an acute phase reactant, rising shortly after viral infection and subsequently falling to baseline...

Full description

Saved in:
Bibliographic Details
Main Authors: Ravi Mehta, Elena Chekmeneva, Stephanie Ascough, Helen Wagstaffe, Loukas Papargyris, Malick Gibani, Ada H. Y. Yuen, Maria Valdivia-Garcia, Caroline Sands, María Gómez-Romero, Ewurabena A. Mills, Vincenzo Sgro, Lydia Slater, Pete Dayananda, Claire Broderick, Jiayun Xu, Myrsini Kaforou, Lynn Maslen, Mahdad Noursadeghi, Andrew J. Pollard, Wendy Barclay, Zoltan Takats, Christopher Chiu, Shiranee Sriskandan
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:npj Viruses
Online Access:https://doi.org/10.1038/s44298-025-00132-x
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract 3’-deoxy-3’,4’-didehydro-cytidine (ddhC) is a recently discovered host biomarker for viral infections, though its temporal kinetics remain unclear. This study tests the hypothesis that ddhC is an acute phase reactant, rising shortly after viral infection and subsequently falling to baseline. We leveraged the precise monitoring facilitated by human challenge studies to investigate healthy participants inoculated with SARS-CoV-2, influenza A virus (H3N2), or respiratory syncytial virus (RSV). Using targeted liquid chromatography-tandem mass spectrometry, we quantified ddhC concentrations in serial plasma samples collected pre- and post-inoculation. In SARS-CoV-2 and H3N2 influenza A virus infection, but not RSV, ddhC levels peaked at 3–7 days post inoculation and declined to baseline by days 10–14. This pattern was also observed in asymptomatic or paucisymptomatic participants. A comparison of ddhC concentrations with matched timepoint whole blood gene expression revealed a correlation with interferon-related genes, including viperin and CMPK2—enzymes implicated in its upstream biosynthesis. Our results suggest that ddhC is a biomarker of the acute phase of viral infection, with potential to guide early interventions that reduce antimicrobial resistance and strengthen pandemic preparedness. Future work should explore ddhC dynamics in natural and experimental infections across varying severities and assess its utility in diverse populations and healthcare settings.
ISSN:2948-1767

Similar Items